A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity is a research paper published in Science Signaling (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: R01 DK126908
NIDDK NIH HHS
Grant: P30 DK020572
NIDDK NIH HHS
Grant: R01 DK090313
NIDDK NIH HHS
Grant: R01 DK132065
NHLBI NIH HHS
Grant: R01 HL130146
NHLBI NIH HHS
Grant: R01 HL134787
National Institutes of Health
Grant: 5P30DK020572-37
ADMINISTRATIVE CORE
National Institutes of Health
Grant: 5R01DK132065-04
Mitochondrial NAD kinase: function and mechanism in metabolism
National Institutes of Health
Grant: 5R01DK126908-04
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
National Institutes of Health
Grant: 5R01DK090313-12
A novel CREBH-derived hepatokine regulates triglyceride metabolism
Fields of Study
MeSH Terms
Keywords